GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TiumBio Co Ltd (XKRX:321550) » Definitions » EV-to-Revenue

TiumBio Co (XKRX:321550) EV-to-Revenue : 14.91 (As of Dec. 12, 2024)


View and export this data going back to 2019. Start your Free Trial

What is TiumBio Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, TiumBio Co's enterprise value is ₩114,348 Mil. TiumBio Co's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was ₩7,671 Mil. Therefore, TiumBio Co's EV-to-Revenue for today is 14.91.

The historical rank and industry rank for TiumBio Co's EV-to-Revenue or its related term are showing as below:

XKRX:321550' s EV-to-Revenue Range Over the Past 10 Years
Min: 14.16   Med: 298.59   Max: 139993.91
Current: 14.91

During the past 7 years, the highest EV-to-Revenue of TiumBio Co was 139993.91. The lowest was 14.16. And the median was 298.59.

XKRX:321550's EV-to-Revenue is ranked worse than
62.38% of 1042 companies
in the Biotechnology industry
Industry Median: 7.635 vs XKRX:321550: 14.91

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-12-12), TiumBio Co's stock price is ₩4070.00. TiumBio Co's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ₩302.17. Therefore, TiumBio Co's PS Ratio for today is 13.47.


TiumBio Co EV-to-Revenue Historical Data

The historical data trend for TiumBio Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TiumBio Co EV-to-Revenue Chart

TiumBio Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial 292.27 414.24 7,814.99 32.10 47.80

TiumBio Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.01 47.80 30.00 20.35 23.26

Competitive Comparison of TiumBio Co's EV-to-Revenue

For the Biotechnology subindustry, TiumBio Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TiumBio Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TiumBio Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where TiumBio Co's EV-to-Revenue falls into.



TiumBio Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

TiumBio Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=114348.250/7670.693
=14.91

TiumBio Co's current Enterprise Value is ₩114,348 Mil.
TiumBio Co's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩7,671 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TiumBio Co  (XKRX:321550) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

TiumBio Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=4070.00/302.173
=13.47

TiumBio Co's share price for today is ₩4070.00.
TiumBio Co's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩302.17.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TiumBio Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of TiumBio Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


TiumBio Co Business Description

Traded in Other Exchanges
N/A
Address
49, Daewangpangyo-ro 644beon-gil, Bundang-gu, 4th floor, Gyeonggi, Seongnam, KOR, 13493
TiumBio Co Ltd is a Biopharmaceutical company. It is engaged in research and development of rare and intractable diseases. The company's products are in pipeline. It offers products such as Idiopathic pulmonary fibrosis therapies, immune chemotherapy, endometriosis therapies, hemophilia.

TiumBio Co Headlines

No Headlines